93.67
price up icon1.11%   1.03
after-market アフターアワーズ: 94.59 0.92 +0.98%
loading
前日終値:
$92.64
開ける:
$93.06
24時間の取引高:
8.30M
Relative Volume:
1.07
時価総額:
$138.54B
収益:
$16.75B
当期純損益:
$1.85B
株価収益率:
74.94
EPS:
1.25
ネットキャッシュフロー:
$2.37B
1週間 パフォーマンス:
+4.43%
1か月 パフォーマンス:
-1.94%
6か月 パフォーマンス:
+7.54%
1年 パフォーマンス:
+36.07%
1日の値動き範囲:
Value
$91.89
$94.48
1週間の範囲:
Value
$85.98
$97.65
52週間の値動き範囲:
Value
$66.80
$107.17

Boston Scientific Corp Stock (BSX) Company Profile

Name
名前
Boston Scientific Corp
Name
セクター
Healthcare (1156)
Name
電話
508-683-4000
Name
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
職員
53,000
Name
Twitter
@bostonsci
Name
次回の収益日
2024-10-23
Name
最新のSEC提出書
Name
BSX's Discussions on Twitter

BSX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
BSX
Boston Scientific Corp
93.67 138.54B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
ABT
Abbott Laboratories
126.88 220.05B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
SYK
Stryker Corp
350.28 132.98B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
82.90 105.84B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
69.40 39.98B 5.72B 4.17B 259.90M 6.97

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 アップグレード Deutsche Bank Hold → Buy
2024-10-18 ダウングレード Needham Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-02-01 アップグレード Mizuho Neutral → Buy
2023-07-19 開始されました Robert W. Baird Outperform
2023-06-30 開始されました CL King Buy
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Buy
2022-12-22 開始されました Mizuho Neutral
2022-12-20 再開されました Citigroup Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-06 開始されました Wolfe Research Outperform
2022-05-27 アップグレード Needham Hold → Buy
2022-04-13 再開されました Truist Buy
2022-03-02 再開されました BofA Securities Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-05-26 ダウングレード Needham Buy → Hold
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Overweight
2020-09-17 開始されました Truist Buy
2020-09-11 開始されました Wolfe Research Peer Perform
2020-04-22 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-04-01 アップグレード Goldman Neutral → Buy
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Buy
2019-12-30 繰り返されました Cowen Outperform
2019-12-19 ダウングレード Needham Strong Buy → Buy
2019-09-05 再開されました JP Morgan Overweight
2019-09-03 再開されました Barclays Overweight
2019-05-13 アップグレード Evercore ISI In-line → Outperform
2018-11-28 開始されました UBS Buy
2018-10-16 開始されました Barclays Overweight
2018-10-02 繰り返されました Morgan Stanley Overweight
2018-09-07 繰り返されました Needham Strong Buy
2018-09-04 アップグレード Jefferies Hold → Buy
2018-07-06 繰り返されました Needham Strong Buy
2018-06-27 開始されました Bernstein Outperform
2018-04-26 繰り返されました Needham Strong Buy
すべてを表示

Boston Scientific Corp (BSX) 最新ニュース

pulisher
Apr 11, 2025

Boston Scientific price target lowered to $113 from $120 at Truist - TipRanks

Apr 11, 2025
pulisher
Apr 11, 2025

Truist Lowers Price Target for Boston Scientific (BSX) Ahead of Q1 Results | BSX Stock News - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Is Boston Scientific Gaining or Losing Market Support? - Benzinga

Apr 10, 2025
pulisher
Apr 10, 2025

Boston Scientific (BSX) Is Considered a Good Investment by Brokers: Is That True? - Yahoo

Apr 10, 2025
pulisher
Apr 10, 2025

Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains? - Nasdaq

Apr 10, 2025
pulisher
Apr 09, 2025

FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave - BioWorld MedTech

Apr 09, 2025
pulisher
Apr 09, 2025

Lobbying Update: $20,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed - Nasdaq

Apr 09, 2025
pulisher
Apr 09, 2025

What to Expect From Boston Scientific’s Q1 2025 Earnings Report - Nasdaq

Apr 09, 2025
pulisher
Apr 09, 2025

Boston Scientific (NYSE:BSX) Announces Robust Q4 Results With Increased Sales And Net Income - Yahoo Finance

Apr 09, 2025
pulisher
Apr 09, 2025

Interventional Neurology Market Deep Research 2025-2032 | - openPR.com

Apr 09, 2025
pulisher
Apr 09, 2025

What To Expect From Boston Scientific’s Q1 2025 Earnings Report - Barchart.com

Apr 09, 2025
pulisher
Apr 07, 2025

PFA non-inferior, even superior, to cryoablation for paroxysmal AF - BioWorld MedTech

Apr 07, 2025
pulisher
Apr 07, 2025

Boston Scientific Insiders Sell US$1.8m Of Stock, Possibly Signalling Caution - Yahoo Finance

Apr 07, 2025
pulisher
Apr 04, 2025

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry - Benzinga

Apr 04, 2025
pulisher
Apr 04, 2025

Health Rounds: Some early breast cancers may not need surgery after chemo - MarketScreener

Apr 04, 2025
pulisher
Apr 03, 2025

Boston Scientific (BSX) Stock Moves -1.55%: What You Should Know - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Tariffs on medical devices could raise healthcare costs - The Business Journals

Apr 03, 2025
pulisher
Apr 03, 2025

Boston Scientific Sued Over Endoscopic Medical Device Patent - Bloomberg Law News

Apr 03, 2025
pulisher
Apr 03, 2025

Boston Scientific (BSX) Faces Pressure from New Tariffs - GuruFocus

Apr 03, 2025
pulisher
Apr 03, 2025

Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha

Apr 03, 2025
pulisher
Apr 03, 2025

Price Over Earnings Overview: Boston Scientific - Benzinga

Apr 03, 2025
pulisher
Apr 03, 2025

Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Is Boston Scientific (NYSE:BSX) A Risky Investment? - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Boston Scientific’s Farapulse matches Medtronic cryoablation in trial - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Boston Scientific CEO Michael Mahoney sells $16.4 million in stock By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 02, 2025

No benefit found for cerebral protection device in TAVR - BioWorld MedTech

Apr 02, 2025
pulisher
Apr 02, 2025

Boston Scientific CEO Michael Mahoney sells $16.4 million in stock - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Boston Scientific closes Bolt Medical acquisition - MassDevice

Apr 02, 2025
pulisher
Apr 02, 2025

Evercore ISI Adjusts Boston Scientific Price Target to $110 From $112, Maintains Outperform Rating - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Boston Scientific Co. (NYSE:BSX) Shares Purchased by Groupama Asset Managment - MarketBeat

Apr 02, 2025
pulisher
Apr 01, 2025

Boston Scientific announces conference call discussing first quarter 2025 results - Quantisnow

Apr 01, 2025
pulisher
Apr 01, 2025

FDA Approval Boosts Boston Scientific's (BSX) Investment in Bolt Medical - GuruFocus

Apr 01, 2025
pulisher
Apr 01, 2025

FDA clears Bolt Medical’s IVL system, backing Boston Scientific’s $664m buyout - Yahoo

Apr 01, 2025
pulisher
Apr 01, 2025

Boston Scientific (BSX): Among the Best Healthcare Stocks to Buy According to Billionaires - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

Boston Scientific Corp (BSX-N) Stock Price and News - The Globe and Mail

Apr 01, 2025
pulisher
Mar 31, 2025

Boston Scientific (BSX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Mar 31, 2025
pulisher
Mar 31, 2025

FDA clears Boston Scientific Bolt IVL system - MassDevice

Mar 31, 2025
pulisher
Mar 31, 2025

Boston Scientific Farapulse PFA system shows superiority in head-to-head study with Medtronic cryoablation system - MassDevice

Mar 31, 2025
pulisher
Mar 31, 2025

Boston Scientific Co. (NYSE:BSX) is Homestead Advisers Corp's 8th Largest Position - MarketBeat

Mar 31, 2025
pulisher
Mar 30, 2025

Boston Scientific Corporation (NYSE:BSX) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? - Yahoo Finance

Mar 30, 2025
pulisher
Mar 29, 2025

Boston Scientific to acquire SoniVie - Today's Medical Developments

Mar 29, 2025
pulisher
Mar 27, 2025

$100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

International Expansion, Product Launches Support BSX Stock - Yahoo Finance

Mar 27, 2025
pulisher
Mar 27, 2025

Goldman Sachs Adjusts Price Target on Boston Scientific to $116 From $119, Maintains Buy Rating - Marketscreener.com

Mar 27, 2025
pulisher
Mar 27, 2025

The Zacks Analyst Blog Highlights Tesla, The Home Depot, Boston Scientific, Frequency Electronics and Bridger Aerospace - Yahoo Finance

Mar 27, 2025
pulisher
Mar 26, 2025

Top Stock Reports for Tesla, Home Depot & Boston Scientific - MSN

Mar 26, 2025
pulisher
Mar 25, 2025

The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic - Yahoo Finance

Mar 25, 2025
pulisher
Mar 24, 2025

Boston Scientific SVP Vance Brown sells shares worth $486,702 By Investing.com - Investing.com Australia

Mar 24, 2025
pulisher
Mar 24, 2025

Market Makes A Big Shift: DoorDash, Heico, Boston Scientific In Focus - Investor's Business Daily

Mar 24, 2025
pulisher
Mar 24, 2025

Boston Scientific SVP Vance Brown sells shares worth $486,702 - Investing.com India

Mar 24, 2025
pulisher
Mar 24, 2025

Returns Are Gaining Momentum At Boston Scientific (NYSE:BSX) - Yahoo Finance

Mar 24, 2025

Boston Scientific Corp (BSX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices SYK
$350.28
price up icon 0.54%
medical_devices MDT
$82.90
price up icon 0.44%
medical_devices ABT
$126.88
price up icon 1.91%
medical_devices EW
$69.40
price up icon 1.67%
$62.81
price up icon 0.85%
大文字化:     |  ボリューム (24 時間):